CRDL
Cardiol Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.88
+0.81%Sep 16, 2026, 11:27 UTC
Cardiol Therapeutics announced the exercise of warrants for over USD 7 million in proceeds, strengthening its balance sheet ahead of Phase III MAVERIC trial data in recurrent pericarditis.
Source:Sep 10, 2026, 21:00 UTC
Cardiol Therapeutics filed a preliminary short form base shelf prospectus for up to US$150 million with Canadian securities regulators and a corresponding Form F-10 registration statement with the US SEC.
Source: